JCO Precision Oncology Report Shows Diagnostic Testing-Informed Treatment Strategies Benefitting Only 36 Percent of Lung Cancer Patients With Potentially Actionable Biomarkers

November 30, 2022•1 min read

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Montana BioScience Alliance

Montana BioScience Alliance is the statewide organization dedicated to advancing and advocating for Montana’s bioscience industry. The Alliance connects researchers, companies, and policymakers to strengthen research, support responsible policy, and drive economic growth across the state.

Back to Blog